Startup Arboretum Sprouts, Bringing a Precision Medicine Approach to Common Diseases

Arboretum LifeSciences, a diagnostics and drug development startup, launched with $30 million in Series A funding. The company combines genetic testing with data analytics to identify disease patterns and inform drug development partnerships with major pharmaceutical firms and spawn new biotech ventures targeting common diseases.